Why I invested in Tactogen

MDMA is a wonderful medicine. This startup company wants to make it even better.

Marc Gunther
The Psychedelic Renaissance
6 min readMay 2, 2023

--

Psychedelic medicines are generating excitement everywhere — among academic researchers and therapists, in the press, even with members of Congress — everywhere, that is, but among investors. Several startups developing psychedelic therapies have gone bust. Shares in others sell for

--

--

Marc Gunther
The Psychedelic Renaissance

Reporting on psychedelics, tobacco, philanthropy, animal welfare, etc. Ex-Fortune. Words in The Guardian, NYTimes, WPost, Vox. Baseball fan. Runner.